Summary: Rolling Stone reports on the results of the historic psychedelic study conducted by researchers from the Centre for Psychedelic Research at Imperial College London. Published in the New England …
Summary: “At MAPS and the Zendo Project, we feel that it is important that, as we explore the potential benefits of psychedelics, we also make room to address the risks associated with psychedelic …
Ayahuasca is a liana. From the forest floor, it winds its way up to the canopy. It is a medicine on its own, sometimes called “the force.” And the liana activates other medicines, like chacruna, “the …
Summary: VICE reports on the ongoing discussion about ethics regarding patent applications of psychedelic substances and psychedelic-assisted therapy, which are on the rise amidst “the explosion …
Summary: The Neuroscape Psychedelics Division was recently established at the University of California, San Francisco (UCSF) to expand psychedelic research! According to Neuroscape, “the new division …
Summary: In an engaging editorial for the British Medical Journal (BMJ) Opinion, Peter Brindley, M.D., encourages “scientific skeptic[s]” to “accept and celebrate the chance to change …
Summary: In the Spring 2021 edition of the Stanford Social Innovation Review, journalist Marc Gunther dives into the decades-long history of MAPS, discussing its founding in 1986 by Rick Doblin, Ph.D., …
Summary: Ezra Klein of the New York Times considers the healing potential of psilocybin mushrooms in an op-ed that covers the success of Oregon’s Measure 109, which creates a “support infrastructure …
Summary: LA Weekly covers the results of a MAPS-sponsored clinical trial of cannabis for the treatment of posttraumatic stress disorder (PTSD) in Veterans, which raised no safety concerns. The article …
Summary: On the Bialik Breakdown, MAPS Founder and Executive Director Rick Doblin, Ph.D., and Mayim Bialik discuss the healing potential of MDMA-assisted therapy, as well as the ancient origins of psychedelic …
Summary: MEL Magazine profiles the late psychedelic chemist Alexander “Sasha” Shulgin, Ph.D., who dedicated decades of his life to synthesizing psychedelic compounds and providing accessible …
Summary: “The national rethink on psychedelic drugs is moving rapidly,” says The Boston Globe in an op-ed that covers the recent launch of the Center for the Neuroscience of Psychedelics at …
